- Case-Based Roundtable
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
- Buy-and-Bill
News
Article
Daily Derm Times: April 3, 2025
Author(s):
Key Takeaways
- The prevalence of atopic dermatitis is stable, but the disease burden is rising, highlighting the need for personalized treatment strategies.
- Early recognition and aggressive treatment of childhood-onset mucous membrane pemphigoid are essential to prevent permanent scarring.
Catch up on dermatology news, highlights, and insights from the past 24 hours.
To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.
Atopic Dermatitis Insights on Global Prevalence, Health Care Implications, and the Impact of COVID-19
Researcher Jiyeon Oh shares results of a recent study that confirm the prevalence of AD is stable, but disease burden is rising.
Multicenter Study Sheds Light on Pediatric MMP
The study stated early recognition and aggressive treatment of childhood-onset MMP are essential to prevent permanent scarring.
Researchers Report Rare Case of Squamous Cell Carcinoma in Sun-Shielded Area in Epidermodysplasia Verruciformis
Researchers reported the case of a 28-year-old woman with epidermodysplasia verruciformis who developed SCC on a sun-protected scalp.
Why Atopic Dermatitis Treatment is Not “One Size Fits All,” According to Jiyeon Oh
Jiyeon Oh’s research confirms that a personalized approach is needed to treat all complexities associated with AD.
Reduced Cardiovascular Risk with Biologics in Psoriasis and PsA
Unlike biologics, nonbiologic systemic therapies showed a neutral or slightly increased cardiovascular risk, raising concerns about their long-term safety.
